✦ LIBER ✦
Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV
✍ Scribed by Hehlmann, R.; Muller, M. C.; Lauseker, M.; Hanfstein, B.; Fabarius, A.; Schreiber, A.; Proetel, U.; Pletsch, N.; Pfirrmann, M.; Haferlach, C.; Schnittger, S.; Einsele, H.; Dengler, J.; Falge, C.; Kanz, L.; Neubauer, A.; Kneba, M.; Stegelmann, F.; Pfreundschuh, M.; Waller, C. F.; Spiekermann, K.; Baerlocher, G. M.; Ehninger, G.; Heim, D.; Heimpel, H.; Nerl, C.; Krause, S. W.; Hossfeld, D. K.; Kolb, H.-J.; Hasford, J.; Saussele, S.; Hochhaus, A.
- Book ID
- 121407654
- Publisher
- American Society of Clinical Oncology
- Year
- 2014
- Tongue
- English
- Weight
- 892 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0732-183X
No coin nor oath required. For personal study only.